loadpatents
name:-0.034343004226685
name:-0.039309024810791
name:-0.0079278945922852
Ohlmeyer; Michael Patent Filings

Ohlmeyer; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ohlmeyer; Michael.The latest application filed is for "dihydropyridines for the treatment of cognitive impairment or traumatic brain injury".

Company Profile
6.24.32
  • Ohlmeyer; Michael - New York NY US
  • Ohlmeyer; Michael - Plainsboro NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Dihydropyridines For The Treatment Of Cognitive Impairment Or Traumatic Brain Injury
App 20210230117 - Ohlmeyer; Michael ;   et al.
2021-07-29
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
Grant 10,759,790 - Ohlmeyer , et al. Sep
2020-09-01
Compositions and methods for treating cancer
Grant 10,744,141 - Goutham , et al. A
2020-08-18
Stereospecific process for 3-heterocyclylcycloaliphatic-1,2-diols
Grant 10,450,282 - Ohlmeyer , et al. Oc
2019-10-22
Cyclic vinylogous amides as bromodomain inhibitors
Grant 10,351,511 - Zhou , et al. July 16, 2
2019-07-16
Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
Grant 10,221,158 - Ohlmeyer , et al.
2019-03-05
Heterocyclic Constrained Tricyclic Sulfonamides As Anti-cancer Agents
App 20180251444 - OHLMEYER; Michael ;   et al.
2018-09-06
Heterocyclic Constrained Tricyclic Sulfonamides As Anti-cancer Agents
App 20180251456 - OHLMEYER; Michael ;   et al.
2018-09-06
Stereospecific Process For 3-heterocyclylcycloaliphatic-1,2-diols
App 20180230112 - OHLMEYER; Michael ;   et al.
2018-08-16
Compositions And Methods For Treating Cancer
App 20180185382 - Narla; Goutham ;   et al.
2018-07-05
Cyclic Vinylogous Amides As Bromodomain Inhibitors
App 20180105485 - ZHOU; Ming-Ming ;   et al.
2018-04-19
Constrained tricyclic sulfonamides
Grant 9,937,180 - Ohlmeyer , et al. April 10, 2
2018-04-10
Sulfonamides derived from tricyclyl-2-aminocycloalkanols as anticancer agents
Grant 9,937,186 - Ohlmeyer , et al. April 10, 2
2018-04-10
Cyclic vinylogous amides as bromodomain inhibitors
Grant 9,884,806 - Zhou , et al. February 6, 2
2018-02-06
Tricyclic Heterocycles As Anticancer Agents
App 20180002339 - OHLMEYER; Michael ;   et al.
2018-01-04
Tricyclic heterocycles as anticancer agents
Grant 9,796,717 - Ohlmeyer , et al. October 24, 2
2017-10-24
Constrained Tricyclic Sulfonamides
App 20170015630 - OHLMEYER; Michael ;   et al.
2017-01-19
Sulfonamides Derived From Tricyclyl-2-aminocycloalkanols As Anticancer Agents
App 20170015625 - OHLMEYER; Michael ;   et al.
2017-01-19
Tricyclic compounds as anticancer agents
Grant 9,540,358 - Ohlmeyer , et al. January 10, 2
2017-01-10
Method and compositions for treating cancer and related methods
Grant 9,494,572 - Narla , et al. November 15, 2
2016-11-15
Cyclic Vinylogous Amides As Bromodomain Inhibitors
App 20160200666 - ZHOU; Ming-Ming ;   et al.
2016-07-14
Tricyclic Heterocycles As Anticancer Agents
App 20150376191 - OHLMEYER; Michael ;   et al.
2015-12-31
Method and compositions for treating cancer and related methods
Grant 9,134,297 - Narla , et al. September 15, 2
2015-09-15
Method and Compositions for Treating Cancer and Related Methods
App 20150224101 - Narla; Goutham ;   et al.
2015-08-13
Lipoprotein lipase-activating compositions comprising benzene derivates
Grant 8,895,599 - Neagu , et al. November 25, 2
2014-11-25
Tricyclic Compounds As Anticancer Agents
App 20140213578 - Ohlmeyer; Michael ;   et al.
2014-07-31
1-(4-ureidobenzoyl)piperazine derivatives
Grant 8,759,352 - Cooke , et al. June 24, 2
2014-06-24
Inhibitors Of Bromodomains As Modulators Of Gene Expression
App 20140066410 - Zhou; Ming-Ming ;   et al.
2014-03-06
Lipoprotein Lipase-activating Compositions Comprising Benzene Derivates
App 20130296342 - NEAGU; Irina ;   et al.
2013-11-07
Method and Compositions for Treating Cancer and Related Methods
App 20120322792 - Narla; Goutham ;   et al.
2012-12-20
N-benzyl,N'-arylcarbonylpiperazine derivatives
Grant 8,314,091 - Ho , et al. November 20, 2
2012-11-20
5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators
Grant 8,211,927 - Roughton , et al. July 3, 2
2012-07-03
1-(4-ureidobenzoyl)piperazine Derivatives
App 20120015958 - Cooke; Andrew John ;   et al.
2012-01-19
PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS
App 20110218189 - Roughton; Andrew Laird ;   et al.
2011-09-08
Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
Grant 7,989,459 - Roughton , et al. August 2, 2
2011-08-02
8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression
Grant 7,915,268 - Lu , et al. March 29, 2
2011-03-29
5- Phenyl-isoxazole-3-carboxamide Derivatives As Trpv1 Modulators
App 20110065764 - Roughton; Andrew Laird ;   et al.
2011-03-17
Lipoprotein Lipase-activating Compositions Comprising Benzene Derivatives
App 20110065728 - Neagu; Irina ;   et al.
2011-03-17
2-(1-oxo-1H-isoquinolin-2-yl)acetamide derivatives
Grant 7,906,504 - Letourneau , et al. March 15, 2
2011-03-15
Purines As Pkc-theta Inhibitors
App 20110046131 - Neagu; Irina ;   et al.
2011-02-24
Quinazolinone and isoquinolinone acetamide derivatives
Grant 7,820,649 - Letourneau , et al. October 26, 2
2010-10-26
2-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists
Grant 7,807,686 - Letourneau , et al. October 5, 2
2010-10-05
N-benzyl,n'-arylcarbonylpiperazine Derivatives
App 20090264416 - Ho; Koc-Kan ;   et al.
2009-10-22
2-(4-Oxo-4H-Quinazolin-3-Yl) Acetamides and Their Use as Vasopressin V3 Antagonists
App 20080214553 - Letourneau; Jeffrey ;   et al.
2008-09-04
Quinazolinone And Isoquinolinone Acetamide Derivatives
App 20080090802 - Letourneau; Jeffrey ;   et al.
2008-04-17
Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
App 20080085909 - Roughton; Andrew ;   et al.
2008-04-10
8-substituted 2-(benzimidazolyl)purine Derivatives For Immunosuppression
App 20080085898 - Lu; Yingchun ;   et al.
2008-04-10
2-(1-oxo-1h-isoquinolin-2-yl)acetamide Derivatives
App 20080064678 - Letourneau; Jeffrey ;   et al.
2008-03-13
Compounds with medicinal effects due to interaction with the glucocorticoid receptor
App 20070149577 - Hamilton; Niall Morton ;   et al.
2007-06-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed